Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
997.5 INR | +4.12% | +3.30% | +31.35% |
Sales 2024 * | 63.38B 761M | Sales 2025 * | 70.38B 845M | Capitalization | 196B 2.35B |
---|---|---|---|---|---|
Net income 2024 * | 5.92B 71.04M | Net income 2025 * | 7.03B 84.39M | EV / Sales 2024 * | 3.13 x |
Net Debt 2024 * | 2.62B 31.42M | Net cash position 2025 * | 457M 5.49M | EV / Sales 2025 * | 2.78 x |
P/E ratio 2024 * |
33
x | P/E ratio 2025 * |
27.8
x | Employees | 14,593 |
Yield 2024 * |
0.89% | Yield 2025 * |
1.01% | Free-Float | 29.28% |
Latest transcript on Alembic Pharmaceuticals Limited
1 day | +4.12% | ||
1 week | +3.30% | ||
Current month | +1.29% | ||
1 month | +4.19% | ||
3 months | +1.64% | ||
6 months | +32.28% | ||
Current year | +31.35% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 83-04-30 | |
Director of Finance/CFO | 64 | 03-01-17 | |
Manisha Saraf
CMP | Compliance Officer | - | 23-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 83-04-30 | |
Director of Finance/CFO | 64 | 03-01-17 | |
Director/Board Member | 56 | 15-02-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 117 M€ | +0.15% | - | |
0.00% | 34 M€ | +1.75% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 997.5 | +4.12% | 136 404 |
24-04-24 | 958 | +1.89% | 60,861 |
24-04-23 | 940.2 | -1.24% | 57,145 |
24-04-22 | 952.1 | +1.47% | 61,662 |
24-04-19 | 938.4 | +0.78% | 69,069 |
Delayed Quote NSE India S.E., April 25, 2024 at 09:03 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.35% | 2.26B | |
+24.17% | 562B | |
-6.09% | 358B | |
+19.90% | 322B | |
+7.72% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-11.74% | 149B | |
-6.07% | 146B |
- Stock Market
- Equities
- APLLTD Stock